ONKURE INC has a total of 23 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2015. It filed its patents most often in China, United States and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AMGEN INC, CURACYTE CHEMISTRY GMBH and F HOFFMAN-LA ROCHE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | United States | 4 | |
#3 | Taiwan | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Japan | 2 | |
#7 | Republic of Korea | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Piscopio Anthony D | 19 |
#2 | Fu Xiaoyong | 14 |
#3 | Liu Huayan | 14 |
#4 | Li Zhifeng | 14 |
#5 | Shi Feng | 14 |
#6 | Anthony D Piscopio | 3 |
#7 | Piscopio Anthony | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017201278A1 | Thioester prodrugs of macrocycles as inhibitors of histone deacetylases | |
TW201613953A | Process for the preparation of cyclic depsipeptides |